BIOREM Inc.
BRM.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.84% | 46.66% | 67.53% | 18.97% | -1.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.84% | 46.66% | 67.53% | 18.97% | -1.12% |
| Cost of Revenue | 36.23% | 48.55% | 56.91% | 17.11% | -4.16% |
| Gross Profit | 6.02% | 41.78% | 95.81% | 23.48% | 6.36% |
| SG&A Expenses | 26.44% | 41.90% | 11.65% | -20.34% | -28.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -3,200.00% | -- | -- |
| Total Operating Expenses | 34.21% | 47.17% | 46.80% | 8.31% | -9.85% |
| Operating Income | -12.12% | 43.04% | 388.58% | 152.85% | 102.46% |
| Income Before Tax | -7.57% | 48.12% | 545.93% | 217.50% | 120.38% |
| Income Tax Expenses | 6.02% | 78.86% | 298.31% | 106.65% | 49.11% |
| Earnings from Continuing Operations | -11.69% | 39.44% | 710.35% | 280.80% | 157.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.69% | 39.44% | 710.35% | 280.80% | 157.71% |
| EBIT | -12.12% | 43.04% | 388.58% | 152.85% | 102.46% |
| EBITDA | -5.90% | 46.75% | 345.47% | 129.18% | 83.47% |
| EPS Basic | -12.07% | 39.51% | 691.83% | 271.33% | 151.92% |
| Normalized Basic EPS | -7.93% | 48.34% | 531.76% | 209.66% | 115.23% |
| EPS Diluted | -34.17% | 10.97% | 730.43% | 334.52% | 178.70% |
| Normalized Diluted EPS | -13.77% | 40.87% | 716.06% | 272.12% | 148.27% |
| Average Basic Shares Outstanding | 4.69% | -0.09% | 0.57% | 0.73% | 1.09% |
| Average Diluted Shares Outstanding | 4.71% | 7.84% | 5.43% | 4.70% | -1.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |